NOVARTIS Stock London S.E.
Stocks
0HKE
CH0012005267
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - GBX | - |
|
| 11:06am | Where would AI lead Pharma in the long run? |  |
| 08:56am | CPI Brings Relief, but Oil Is Back in Charge |  |
| Market Cap | 281B 246B 228B 210B 397B 26,869B 405B 2,718B 1,066B 13,195B 1,054B 1,031B 45,568B | P/E 2026 * |
21.4x | P/E 2027 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise Value | 313B 274B 254B 234B 442B 29,932B 451B 3,028B 1,188B 14,699B 1,174B 1,149B 50,763B | EV / Sales 2026 * |
5.5x | EV / Sales 2027 * | 5.13x |
| Free-Float |
91.66% | Yield 2026 * |
2.87% | Yield 2027 * | 2.96% |
Last Transcript: NOVARTIS
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2018-01-31 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 2026-03-15 |
Shreeram Aradhye
CTO | Chief Tech/Sci/R&D Officer | 64 | 2022-05-15 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 2014-12-31 |
| Director/Board Member | 69 | 2015-12-31 | |
Ton Büchner
BRD | Director/Board Member | 61 | 2015-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.35% | -7.09% | +43.62% | +155.42% | 1,054B | |
| -1.80% | -5.45% | +61.13% | +58.06% | 621B | |
| -1.25% | -4.01% | +27.63% | +79.71% | 438B | |
| -1.33% | -3.83% | +26.70% | +20.39% | 325B | |
| -1.86% | -13.77% | +16.17% | +19.97% | 262B | |
| -1.45% | -2.37% | -27.87% | -39.87% | 219B | |
| -0.96% | -3.05% | +20.15% | +56.92% | 195B | |
| -0.85% | -4.47% | +16.22% | +68.77% | 163B | |
| -1.12% | +0.44% | -4.64% | -33.44% | 140B | |
| Average | -1.43% | -1.30% | +19.90% | +42.88% | 379.45B | |
| Weighted average by Cap. | -1.72% | -1.59% | +31.84% | +74.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 56.83B 49.84B 46.16B 42.47B 80.34B 5,439B 81.9B 550B 216B 2,671B 213B 209B 9,224B | 60.24B 52.84B 48.94B 45.03B 85.17B 5,766B 86.83B 583B 229B 2,831B 226B 221B 9,778B |
| Net income | 14.08B 12.35B 11.44B 10.52B 19.9B 1,348B 20.29B 136B 53.46B 662B 52.87B 51.71B 2,285B | 15.64B 13.72B 12.71B 11.69B 22.12B 1,497B 22.55B 151B 59.4B 735B 58.74B 57.46B 2,539B |
| Net Debt | 32B 28.07B 26B 23.92B 45.25B 3,063B 46.13B 310B 122B 1,504B 120B 118B 5,195B | 28.5B 25B 23.15B 21.3B 40.3B 2,728B 41.08B 276B 108B 1,340B 107B 105B 4,627B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- NOVN Stock
- 0HKE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
